Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Short Interest Update

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 10,300 shares, a drop of 78.5% from the May 15th total of 47,800 shares. Based on an average daily trading volume, of 81,900 shares, the days-to-cover ratio is currently 0.1 days. Currently, 2.1% of the company’s stock are sold short.

Virtus LifeSci Biotech Clinical Trials ETF Trading Down 2.1%

Shares of NYSEARCA:BBC opened at $20.22 on Thursday. Virtus LifeSci Biotech Clinical Trials ETF has a one year low of $13.42 and a one year high of $31.65. The business’s 50-day simple moving average is $17.79 and its 200 day simple moving average is $20.91.

About Virtus LifeSci Biotech Clinical Trials ETF

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.